[en] Miconazole is an antimycotic drug exhibiting a very poor water solubility (B1.03 mg:ml). It has been shown that cyclodextrins (CDs) are able to form inclusion complexes with miconazole and that they are able to increase its aqueous solubility. Miconazole is a weak base whose solubility depends of the pH. The purpose of this study was to investigate the influence of both CDs and different acids on the solubility of miconazole. It was found that a synergistic effect existed between CDs and different acids. The combination of hydroxypropyl-bCD (HP-bCD) (100 mM) or sulfobutylether 7-bCD (SBE7-bCD) (50 mM) and lactic acid (50 mM) allowed to dissolve more than 10 mg of miconazole per ml. NMR studies confirmed the formation of an inclusion complex miconazole–CD in an acidic medium. It was also shown by the NMR studies that the complex formed was a 1:1 complex. These results demonstrate that it is possible to develop a parenteral aqueous solution of miconazole without surfactant.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Piel, Géraldine ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique et magistrale
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Fillet, Marianne ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Llabres, Gabriel ; Université de Liège - ULiège > Département de physique > Département de physique
Delattre, Luc ; Université de Liège - ULiège > Département de pharmacie > Département de pharmacie
Language :
English
Title :
Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins
Bononi, L.J., 1995. Beta-cyclodextrin complexes of miconazole and econazole. US patent 5 422 347, June 6.
Brewster, M.E., Estes, K.S., Bodor, N., 1989. Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins. J. Parenteral Sci. Technol. 43 (6), 262-265.
Brewster, M.E., Estes, K.S., Bodor, N., 1990. An intravenous toxicity study of hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and in monkeys. Int. J. Pharm. 59, 231-243.
Caporal-Gauthier, J., Nivet, J.M., Algrande, P., 1992. Guide de validation analytique: rapport d'une commision SFSTP. I: méthodologie. STP Pharma Pratiques 2 (4), 205-206.
Djedaïni, F., Perly, B., 1991. In: Duchêne, D. (Ed.), New Trends in Cyclodextrins. de Santé, Paris.
Hopkins, C.S., 1988. Adverse reaction to a cremophor containing preparation of intravenous vitamin. Intensive Ther. Clin. Monit. 9, 254-255.
Howrie, D.L., Ptachcinski, R.J., Griffith, B.P., Hadersty, R.J., Venkataramanan, R., 1984. Anaphylactoid reactions associated with parenteral cyclosporine use: possible role of cremophor EL. Drug Intell. Clin. Pharm. 19, 425-427.
Mura, P., Liguori, A., Bramanti, G., Bettinetti, G., Campisi, E., Faggi, E., 1992. Improvement of dissolution properties and microbiological activity of miconazole and econazole by cyclodextrin complexation. Eur. J. Pharm. Biopharm. 38 (3), 119-123.
Pedersen, M., Pedersen, S., Sorensen, A.M., 1993a. Polymorphism of miconazole during preparation of solid systems of the drug and β-cyclodextrins. Pharm. Acta Helv. 68, 43-47.
Pedersen, M., Edelsten, M., Nielsen, V.F., Scarpellini, A., Skytte, S., Slot, C., 1993b. Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole. Int. J. Pharm. 90, 247-254.
Pedersen, M., 1994. Isolation and antimycotic effect of a genuine miconazole β-cyclodextrin complex. Eur. J. Pharm. Biopharm. 40 (1), 19-23.
Piel, G., Evrard, B., Delattre, L., 1997. Complexes à multicomposants de miconazole avec différents acides et cyclodextrines. J. Pharm. Belg. 52 (3), 124.
Reynolds, D.J., Aronson, J.K., 1992. Selected side effects Part 8. Anaphylactoid reaction to intravenous vitamin K. Prescr. J. 32 (4), 167-170.
Stella, V.J., 1996. SBE7-βCD, a new novel and safe polyanionic β-CD derivative: characterization and biomedical applications. In: Proceedings of the Eighth International Symposium on CD, pp. 471-476.
Van Doorne, H., Bosch, E.H., Lerk, C.F., 1988a. Formation and antimicrobial activity of complexes of β-cyclodextrin and some antimycotic imidazole derivatives. Pharm. Weekbl. 10, 80-85.
Van Doorne, H., Bosch, E.H., Lerk, C.F., 1988b. Interactions between cyclodextrins and some antimycotic imidazole derivatives: studies on solubility and antimicrobial activity. In: Proceedings of the Fourth International Symposium on Cyclodextrins, pp. 285-291.
Yoshida, A., 1988. Pharmaceutical evaluation of hydroxyalkylethers of β-cyclodextrin. Int. J. Pharm. 46, 217-222.
